Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou6f2
|
ENSMUSG00000009734.11 | POU domain, class 6, transcription factor 2 |
Pou4f2
|
ENSMUSG00000031688.3 | POU domain, class 4, transcription factor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_78436240_78436642 | Pou4f2 | 204 | 0.946180 | 0.88 | 2.0e-18 | Click! |
chr8_78437254_78437558 | Pou4f2 | 761 | 0.676283 | 0.76 | 1.6e-11 | Click! |
chr8_78436795_78436946 | Pou4f2 | 225 | 0.939118 | 0.75 | 5.6e-11 | Click! |
chr8_78426600_78426751 | Pou4f2 | 9970 | 0.203321 | 0.67 | 2.0e-08 | Click! |
chr8_78420139_78420551 | Pou4f2 | 16300 | 0.190202 | 0.67 | 2.6e-08 | Click! |
chr13_18280895_18281049 | Pou6f2 | 94486 | 0.077154 | 0.89 | 6.1e-20 | Click! |
chr13_18281120_18281485 | Pou6f2 | 94816 | 0.076799 | 0.89 | 6.9e-20 | Click! |
chr13_18324103_18324274 | Pou6f2 | 57851 | 0.146319 | 0.84 | 1.3e-15 | Click! |
chr13_18282915_18283066 | Pou6f2 | 96504 | 0.075013 | 0.79 | 1.0e-12 | Click! |
chr13_18282734_18282900 | Pou6f2 | 96331 | 0.075194 | 0.78 | 2.1e-12 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_81629318_81629676 | 36.04 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
3642 |
0.24 |
chr14_64595318_64595919 | 27.20 |
Mir3078 |
microRNA 3078 |
4433 |
0.18 |
chr18_34137254_34137599 | 26.21 |
Gm5238 |
predicted gene 5238 |
11709 |
0.17 |
chr14_12338097_12338549 | 25.54 |
Gm24578 |
predicted gene, 24578 |
4419 |
0.14 |
chr16_63806441_63806811 | 24.61 |
Epha3 |
Eph receptor A3 |
56787 |
0.15 |
chr13_84064676_84065083 | 23.43 |
Gm17750 |
predicted gene, 17750 |
107 |
0.97 |
chr5_111595440_111595747 | 23.34 |
Gm42489 |
predicted gene 42489 |
1977 |
0.36 |
chr13_15544401_15544592 | 22.63 |
Gli3 |
GLI-Kruppel family member GLI3 |
80516 |
0.08 |
chr4_110287470_110287673 | 22.30 |
Elavl4 |
ELAV like RNA binding protein 4 |
44 |
0.99 |
chr3_45385015_45385410 | 22.15 |
Pcdh10 |
protocadherin 10 |
2579 |
0.24 |
chr16_43502947_43503194 | 21.51 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
544 |
0.83 |
chr7_51627192_51627643 | 20.95 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
2063 |
0.32 |
chr13_83736071_83736420 | 20.60 |
Gm33366 |
predicted gene, 33366 |
2290 |
0.18 |
chr10_105381292_105381479 | 20.19 |
Gm48205 |
predicted gene, 48205 |
3909 |
0.23 |
chr14_12189722_12190070 | 20.06 |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
47 |
0.98 |
chr4_87651182_87651681 | 19.99 |
Gm12604 |
predicted gene 12604 |
70642 |
0.13 |
chr4_21665942_21666298 | 19.76 |
Gm11876 |
predicted gene 11876 |
4920 |
0.2 |
chr17_9579512_9579944 | 19.05 |
Gm49807 |
predicted gene, 49807 |
30037 |
0.21 |
chr10_11875450_11875661 | 19.01 |
Gm48697 |
predicted gene, 48697 |
33624 |
0.16 |
chr5_4821349_4821771 | 19.01 |
Gm43112 |
predicted gene 43112 |
1067 |
0.39 |
chr5_147155422_147155776 | 18.74 |
Gsx1 |
GS homeobox 1 |
33097 |
0.12 |
chr12_99011149_99011587 | 18.72 |
Gm47109 |
predicted gene, 47109 |
18359 |
0.16 |
chr4_62613321_62613879 | 18.59 |
Rgs3 |
regulator of G-protein signaling 3 |
5920 |
0.18 |
chr13_71507941_71508418 | 18.58 |
1700112M02Rik |
RIKEN cDNA 1700112M02 gene |
20572 |
0.26 |
chr12_49480483_49481047 | 18.47 |
1810007C17Rik |
RIKEN cDNA 1810007C17 gene |
97 |
0.97 |
chr10_43887790_43887990 | 17.98 |
Qrsl1 |
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 |
7651 |
0.18 |
chr1_93079597_93080373 | 17.98 |
Kif1a |
kinesin family member 1A |
2436 |
0.23 |
chr6_12488973_12489183 | 17.57 |
Thsd7a |
thrombospondin, type I, domain containing 7A |
66035 |
0.12 |
chr1_176099027_176099243 | 17.40 |
Gm38081 |
predicted gene, 38081 |
66412 |
0.1 |
chr6_16317109_16317303 | 17.26 |
Gm3148 |
predicted gene 3148 |
79579 |
0.1 |
chr5_131645868_131646247 | 17.08 |
Gm43483 |
predicted gene 43483 |
3250 |
0.16 |
chr12_58619814_58620024 | 16.99 |
Gm18873 |
predicted gene, 18873 |
143987 |
0.04 |
chr2_63574108_63574289 | 16.92 |
Gm23503 |
predicted gene, 23503 |
142004 |
0.05 |
chr10_29143863_29144732 | 16.78 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr9_84278752_84279064 | 16.64 |
Gm26146 |
predicted gene, 26146 |
90553 |
0.08 |
chr2_105720796_105721112 | 16.15 |
Gm13954 |
predicted gene 13954 |
11955 |
0.18 |
chr6_36644686_36644907 | 16.09 |
Gm2189 |
predicted gene 2189 |
4530 |
0.27 |
chr10_46718838_46719012 | 16.06 |
Gm19994 |
predicted gene, 19994 |
48781 |
0.16 |
chr3_51544955_51545119 | 15.99 |
Setd7 |
SET domain containing (lysine methyltransferase) 7 |
6283 |
0.11 |
chr2_146723404_146723580 | 15.87 |
Gm14111 |
predicted gene 14111 |
32213 |
0.21 |
chr9_52188303_52188475 | 15.52 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19817 |
0.2 |
chr13_90644333_90644489 | 15.24 |
Gm36966 |
predicted gene, 36966 |
10326 |
0.25 |
chr18_62863041_62863580 | 14.99 |
Gm50128 |
predicted gene, 50128 |
58791 |
0.11 |
chr17_15371910_15372469 | 14.95 |
Dll1 |
delta like canonical Notch ligand 1 |
358 |
0.85 |
chr16_44493953_44494153 | 14.74 |
Cfap44 |
cilia and flagella associated protein 44 |
23609 |
0.19 |
chr1_42703489_42704501 | 14.65 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4057 |
0.16 |
chr4_117379821_117380196 | 14.22 |
Rnf220 |
ring finger protein 220 |
4551 |
0.2 |
chr1_126700521_126700711 | 14.00 |
Nckap5 |
NCK-associated protein 5 |
37574 |
0.23 |
chr4_5797861_5798079 | 13.90 |
Fam110b |
family with sequence similarity 110, member B |
114 |
0.98 |
chr3_51963938_51964089 | 13.85 |
Gm20089 |
predicted gene, 20089 |
16928 |
0.12 |
chr5_16134186_16134593 | 13.71 |
Gm43490 |
predicted gene 43490 |
27260 |
0.22 |
chr15_28922580_28922731 | 13.71 |
Gm49280 |
predicted gene, 49280 |
67651 |
0.14 |
chr2_56662653_56662850 | 13.60 |
Mir195b |
microRNA 195b |
123060 |
0.06 |
chr6_112426110_112426371 | 13.37 |
Gm44336 |
predicted gene, 44336 |
32423 |
0.13 |
chr18_59062171_59062581 | 13.23 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
86 |
0.98 |
chr16_26999649_26999947 | 13.16 |
Gmnc |
geminin coiled-coil domain containing |
8146 |
0.32 |
chr10_39672573_39673015 | 13.03 |
Gm8899 |
predicted gene 8899 |
10705 |
0.13 |
chr2_115132444_115132637 | 13.03 |
Gm28493 |
predicted gene 28493 |
3010 |
0.35 |
chr16_85110453_85110900 | 12.97 |
Gm49227 |
predicted gene, 49227 |
30565 |
0.15 |
chr5_64476669_64477265 | 12.88 |
C030018K13Rik |
RIKEN cDNA C030018K13 gene |
41 |
0.96 |
chr1_172048212_172048493 | 12.84 |
Nhlh1 |
nescient helix loop helix 1 |
9221 |
0.11 |
chr2_76017109_76017260 | 12.72 |
Pde11a |
phosphodiesterase 11A |
11141 |
0.19 |
chr1_106072020_106072314 | 12.65 |
Gm37372 |
predicted gene, 37372 |
3727 |
0.22 |
chr5_46150385_46150536 | 12.53 |
4930405L22Rik |
RIKEN cDNA 4930405L22 gene |
218051 |
0.02 |
chr11_88702380_88702633 | 12.43 |
Msi2 |
musashi RNA-binding protein 2 |
15595 |
0.18 |
chr16_7374266_7374456 | 12.39 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
21391 |
0.3 |
chr3_17616549_17616970 | 12.39 |
Gm38154 |
predicted gene, 38154 |
53929 |
0.16 |
chr2_138897117_138897288 | 12.36 |
Gm14067 |
predicted gene 14067 |
19730 |
0.22 |
chrX_130820134_130820324 | 12.27 |
Gm26209 |
predicted gene, 26209 |
67549 |
0.13 |
chr15_18190039_18190239 | 12.10 |
Gm8318 |
predicted gene 8318 |
26258 |
0.22 |
chr10_83106098_83106397 | 12.04 |
1700025N21Rik |
RIKEN cDNA 1700025N21 gene |
35791 |
0.15 |
chr4_68022895_68023332 | 12.03 |
Gm11751 |
predicted gene 11751 |
82 |
0.98 |
chr3_121686605_121686825 | 11.90 |
4930432M17Rik |
RIKEN cDNA 4930432M17 gene |
15398 |
0.11 |
chr15_94288144_94288295 | 11.76 |
Adamts20 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 20 |
116039 |
0.07 |
chr10_18742688_18742839 | 11.73 |
Gm32926 |
predicted gene, 32926 |
706 |
0.52 |
chr10_46922929_46923148 | 11.69 |
Gm47562 |
predicted gene, 47562 |
66536 |
0.12 |
chr2_74210376_74210541 | 11.66 |
Gm13667 |
predicted gene 13667 |
74701 |
0.09 |
chr1_56345109_56345287 | 11.61 |
Gm28900 |
predicted gene 28900 |
106209 |
0.08 |
chr3_78792451_78792970 | 11.59 |
Gm18952 |
predicted gene, 18952 |
34091 |
0.19 |
chr16_89530496_89531006 | 11.54 |
Krtap7-1 |
keratin associated protein 7-1 |
22428 |
0.15 |
chr12_58512603_58512786 | 11.37 |
Clec14a |
C-type lectin domain family 14, member a |
243404 |
0.02 |
chrX_157051721_157051918 | 11.37 |
Gm22666 |
predicted gene, 22666 |
2136 |
0.38 |
chrX_169838405_169838582 | 11.29 |
Mid1 |
midline 1 |
10334 |
0.25 |
chr13_116087573_116087936 | 11.25 |
Gm47893 |
predicted gene, 47893 |
8281 |
0.29 |
chrX_69518088_69518368 | 11.24 |
Gm8172 |
predicted pseudogene 8172 |
88017 |
0.1 |
chr1_111699249_111699400 | 11.21 |
Gm8173 |
predicted gene 8173 |
108451 |
0.07 |
chr1_104838299_104838478 | 11.18 |
n-R5s216 |
nuclear encoded rRNA 5S 216 |
42647 |
0.14 |
chr5_90987721_90988058 | 11.17 |
Epgn |
epithelial mitogen |
39575 |
0.11 |
chr13_63627695_63627846 | 11.01 |
Gm30709 |
predicted gene, 30709 |
391 |
0.82 |
chr13_99459018_99459548 | 10.96 |
Map1b |
microtubule-associated protein 1B |
11663 |
0.18 |
chr14_12337795_12337982 | 10.92 |
Gm24578 |
predicted gene, 24578 |
3984 |
0.15 |
chr4_63459173_63459841 | 10.91 |
Whrn |
whirlin |
1795 |
0.32 |
chr13_71558486_71558841 | 10.84 |
Gm47811 |
predicted gene, 47811 |
66311 |
0.11 |
chr3_50881765_50882103 | 10.83 |
Gm37548 |
predicted gene, 37548 |
5125 |
0.23 |
chr3_69178073_69178240 | 10.78 |
Arl14 |
ADP-ribosylation factor-like 14 |
44263 |
0.1 |
chr2_116019191_116019400 | 10.74 |
Meis2 |
Meis homeobox 2 |
22751 |
0.19 |
chr14_12595344_12595630 | 10.70 |
Gm17805 |
predicted gene, 17805 |
23181 |
0.19 |
chr3_86701365_86701548 | 10.59 |
Gm3788 |
predicted gene 3788 |
29288 |
0.19 |
chr10_126680635_126680862 | 10.59 |
Gm40797 |
predicted gene, 40797 |
16750 |
0.16 |
chr12_50712764_50712915 | 10.59 |
Gm48779 |
predicted gene, 48779 |
40258 |
0.19 |
chr5_77122985_77123232 | 10.52 |
Gm15831 |
predicted gene 15831 |
760 |
0.55 |
chr15_85994312_85994712 | 10.51 |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
15782 |
0.19 |
chr11_14350536_14350733 | 10.46 |
Gm12006 |
predicted gene 12006 |
136979 |
0.05 |
chr6_40138217_40138378 | 10.43 |
Gm26638 |
predicted gene, 26638 |
19518 |
0.16 |
chr1_165914170_165914334 | 10.43 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
969 |
0.48 |
chr15_39769128_39769279 | 10.43 |
Dcstamp |
dendrocyte expressed seven transmembrane protein |
23259 |
0.17 |
chr14_105664904_105665158 | 10.41 |
Gm10076 |
predicted gene 10076 |
16797 |
0.17 |
chr11_22017536_22017834 | 10.37 |
Otx1 |
orthodenticle homeobox 1 |
14788 |
0.25 |
chr17_8368820_8369004 | 10.32 |
T2 |
brachyury 2 |
3484 |
0.15 |
chr4_12263214_12263380 | 10.29 |
Gm11846 |
predicted gene 11846 |
8102 |
0.21 |
chr16_90656578_90657003 | 10.29 |
Gm49715 |
predicted gene, 49715 |
11537 |
0.15 |
chr3_144318847_144319062 | 10.26 |
Gm43447 |
predicted gene 43447 |
1260 |
0.5 |
chr1_54762260_54762411 | 10.26 |
Ankrd44 |
ankyrin repeat domain 44 |
1393 |
0.4 |
chr2_55436079_55436834 | 10.23 |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
486 |
0.86 |
chr3_52575305_52575472 | 10.20 |
Gm10293 |
predicted pseudogene 10293 |
37447 |
0.17 |
chr13_104616089_104616285 | 10.15 |
2610204G07Rik |
RIKEN cDNA 2610204G07 gene |
68744 |
0.13 |
chr14_52331212_52331368 | 10.11 |
Sall2 |
spalt like transcription factor 2 |
2528 |
0.13 |
chr2_68283403_68283554 | 10.05 |
Stk39 |
serine/threonine kinase 39 |
32122 |
0.22 |
chr14_76032657_76033188 | 10.04 |
Gtf2f2 |
general transcription factor IIF, polypeptide 2 |
22057 |
0.18 |
chr9_74925390_74925925 | 10.03 |
Fam214a |
family with sequence similarity 214, member A |
27227 |
0.15 |
chr14_74360274_74360440 | 10.03 |
4933402J15Rik |
RIKEN cDNA 4933402J15 gene |
4830 |
0.27 |
chr4_111686063_111686242 | 9.99 |
Spata6 |
spermatogenesis associated 6 |
33832 |
0.2 |
chr18_47608493_47608845 | 9.96 |
Gm5095 |
predicted gene 5095 |
70934 |
0.1 |
chr12_41308865_41309016 | 9.92 |
Gm47376 |
predicted gene, 47376 |
39150 |
0.15 |
chrX_109969856_109970177 | 9.89 |
Gm4991 |
predicted gene 4991 |
59795 |
0.17 |
chr1_118434982_118435260 | 9.89 |
Clasp1 |
CLIP associating protein 1 |
15397 |
0.13 |
chr14_12220533_12220842 | 9.88 |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
1741 |
0.37 |
chr14_78132773_78132953 | 9.83 |
Fam216b |
family with sequence similarity 216, member B |
43856 |
0.12 |
chr18_47246956_47247284 | 9.83 |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
34075 |
0.17 |
chr4_131432917_131433068 | 9.83 |
Gm831 |
predicted gene 831 |
54205 |
0.16 |
chr16_63806861_63807216 | 9.83 |
Epha3 |
Eph receptor A3 |
56375 |
0.15 |
chr11_72086658_72087016 | 9.83 |
Pitpnm3 |
PITPNM family member 3 |
25276 |
0.13 |
chr5_150894457_150894771 | 9.80 |
Gm43298 |
predicted gene 43298 |
11972 |
0.2 |
chr11_12376762_12376913 | 9.80 |
Cobl |
cordon-bleu WH2 repeat |
1441 |
0.54 |
chr1_6760870_6761068 | 9.75 |
St18 |
suppression of tumorigenicity 18 |
23394 |
0.23 |
chr6_96286333_96286534 | 9.73 |
1700123L14Rik |
RIKEN cDNA 1700123L14 gene |
120190 |
0.06 |
chr16_76866459_76866678 | 9.67 |
1700041M19Rik |
RIKEN cDNA 1700041M19 gene |
22713 |
0.18 |
chr11_96742009_96742301 | 9.66 |
Gm11537 |
predicted gene 11537 |
24647 |
0.11 |
chr19_15230311_15230538 | 9.62 |
Gm5513 |
predicted pseudogene 5513 |
269658 |
0.02 |
chr5_35454198_35454812 | 9.56 |
Gm43377 |
predicted gene 43377 |
58407 |
0.08 |
chr3_106981559_106981710 | 9.55 |
Kcna3 |
potassium voltage-gated channel, shaker-related subfamily, member 3 |
54535 |
0.11 |
chr14_47718027_47718185 | 9.55 |
Ktn1 |
kinectin 1 |
3429 |
0.23 |
chr5_120271282_120271459 | 9.51 |
Gm42655 |
predicted gene 42655 |
16112 |
0.17 |
chr2_6255617_6255768 | 9.49 |
Gm13383 |
predicted gene 13383 |
1574 |
0.38 |
chr14_69991909_69992090 | 9.49 |
Gm33524 |
predicted gene, 33524 |
65368 |
0.09 |
chr7_91430025_91430221 | 9.48 |
Gm22080 |
predicted gene, 22080 |
37434 |
0.16 |
chr3_134605829_134605980 | 9.46 |
Gm26820 |
predicted gene, 26820 |
24861 |
0.25 |
chr8_8640321_8640505 | 9.42 |
Efnb2 |
ephrin B2 |
1050 |
0.28 |
chr16_6962238_6962419 | 9.41 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
107518 |
0.08 |
chr11_12559074_12559282 | 9.40 |
Cobl |
cordon-bleu WH2 repeat |
94218 |
0.08 |
chr2_17841640_17841809 | 9.39 |
Gm13323 |
predicted gene 13323 |
43740 |
0.16 |
chr1_55659939_55660127 | 9.34 |
Plcl1 |
phospholipase C-like 1 |
41992 |
0.18 |
chr2_19519871_19520129 | 9.32 |
Gm13345 |
predicted gene 13345 |
10683 |
0.16 |
chr3_66326335_66326732 | 9.32 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
29696 |
0.18 |
chr6_23876800_23877084 | 9.31 |
Cadps2 |
Ca2+-dependent activator protein for secretion 2 |
37521 |
0.2 |
chr1_96346717_96347057 | 9.24 |
Gm37076 |
predicted gene, 37076 |
33645 |
0.18 |
chr4_5798386_5798616 | 9.21 |
Fam110b |
family with sequence similarity 110, member B |
417 |
0.89 |
chr1_39251725_39251908 | 9.18 |
Gm20428 |
predicted gene 20428 |
24749 |
0.16 |
chr13_29015223_29015589 | 9.14 |
A330102I10Rik |
RIKEN cDNA A330102I10 gene |
887 |
0.68 |
chr7_79525861_79526321 | 9.12 |
Mir9-3hg |
Mir9-3 host gene |
1759 |
0.18 |
chr13_107588484_107588635 | 9.11 |
Gm32004 |
predicted gene, 32004 |
23228 |
0.19 |
chr9_70181794_70181945 | 9.10 |
Myo1e |
myosin IE |
25481 |
0.15 |
chr8_99667776_99667985 | 9.08 |
Gm8688 |
predicted gene 8688 |
3861 |
0.36 |
chr3_115632400_115632573 | 9.07 |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
82586 |
0.08 |
chr5_116209140_116209331 | 9.06 |
Gm14507 |
predicted gene 14507 |
34471 |
0.13 |
chr5_9623115_9623489 | 9.05 |
Gm42455 |
predicted gene 42455 |
20695 |
0.24 |
chr6_56027503_56027697 | 9.02 |
Ppp1r17 |
protein phosphatase 1, regulatory subunit 17 |
10103 |
0.28 |
chr10_52577862_52578221 | 9.00 |
Gm36065 |
predicted gene, 36065 |
15971 |
0.14 |
chr3_72790721_72790890 | 9.00 |
Gm22451 |
predicted gene, 22451 |
52824 |
0.17 |
chr16_97170142_97171160 | 8.97 |
Dscam |
DS cell adhesion molecule |
101 |
0.98 |
chr11_109903041_109903215 | 8.95 |
Gm11697 |
predicted gene 11697 |
33188 |
0.15 |
chr15_88978578_88978828 | 8.95 |
Mlc1 |
megalencephalic leukoencephalopathy with subcortical cysts 1 homolog (human) |
304 |
0.8 |
chr3_107066739_107066904 | 8.92 |
A930002I21Rik |
RIKEN cDNA A930002I21 gene |
24059 |
0.12 |
chr13_25933434_25933585 | 8.90 |
Gm11351 |
predicted gene 11351 |
32807 |
0.24 |
chr5_84690953_84691175 | 8.88 |
Gm43531 |
predicted gene 43531 |
72358 |
0.13 |
chr5_106640571_106640740 | 8.88 |
Gm43421 |
predicted gene 43421 |
15058 |
0.12 |
chr1_155605487_155606141 | 8.86 |
Acbd6 |
acyl-Coenzyme A binding domain containing 6 |
38566 |
0.17 |
chr3_76468131_76468322 | 8.83 |
Gm37897 |
predicted gene, 37897 |
78465 |
0.11 |
chr17_9725703_9726083 | 8.80 |
Gm34684 |
predicted gene, 34684 |
460 |
0.85 |
chr14_65970423_65970776 | 8.73 |
Clu |
clusterin |
21 |
0.97 |
chr19_41745643_41746338 | 8.71 |
Slit1 |
slit guidance ligand 1 |
2325 |
0.31 |
chr5_8819792_8819943 | 8.69 |
Abcb1b |
ATP-binding cassette, sub-family B (MDR/TAP), member 1B |
5423 |
0.17 |
chr19_30637578_30637729 | 8.66 |
Prkg1 |
protein kinase, cGMP-dependent, type I |
12162 |
0.25 |
chr9_82807267_82807418 | 8.64 |
Irak1bp1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
22198 |
0.24 |
chr10_95040613_95040821 | 8.64 |
Gm48867 |
predicted gene, 48867 |
41275 |
0.14 |
chr5_116208794_116209040 | 8.63 |
Gm14507 |
predicted gene 14507 |
34789 |
0.12 |
chr15_44814861_44815012 | 8.59 |
Sybu |
syntabulin (syntaxin-interacting) |
26873 |
0.18 |
chr4_130836300_130836634 | 8.55 |
Gm26716 |
predicted gene, 26716 |
10154 |
0.12 |
chr12_29526481_29526772 | 8.51 |
Myt1l |
myelin transcription factor 1-like |
1758 |
0.41 |
chr10_96545843_96546006 | 8.50 |
Gm48505 |
predicted gene, 48505 |
21942 |
0.18 |
chr13_52457883_52458068 | 8.49 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
73304 |
0.12 |
chr2_123799511_123799723 | 8.49 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
290352 |
0.01 |
chr2_106512677_106513062 | 8.47 |
Gm14015 |
predicted gene 14015 |
10234 |
0.26 |
chr5_144542770_144543233 | 8.46 |
Nptx2 |
neuronal pentraxin 2 |
2901 |
0.34 |
chr8_30921424_30921593 | 8.44 |
Gm45252 |
predicted gene 45252 |
82400 |
0.1 |
chr4_80853016_80853175 | 8.42 |
Tyrp1 |
tyrosinase-related protein 1 |
6507 |
0.29 |
chr9_33630065_33630387 | 8.41 |
Gm47778 |
predicted gene, 47778 |
32861 |
0.21 |
chr15_31661813_31662148 | 8.38 |
Gm46522 |
predicted gene, 46522 |
6414 |
0.19 |
chr2_40643754_40643928 | 8.37 |
Lrp1b |
low density lipoprotein-related protein 1B |
13547 |
0.29 |
chr12_50295690_50295854 | 8.36 |
Gm40418 |
predicted gene, 40418 |
175463 |
0.03 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.3 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
3.1 | 9.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.0 | 9.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
2.6 | 7.9 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
2.6 | 7.9 | GO:0030070 | insulin processing(GO:0030070) |
2.6 | 7.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.2 | 10.9 | GO:0019532 | oxalate transport(GO:0019532) |
1.9 | 9.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.9 | 7.4 | GO:0046959 | habituation(GO:0046959) |
1.8 | 5.5 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
1.8 | 5.5 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.8 | 7.2 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
1.7 | 5.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.7 | 5.0 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.7 | 5.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.7 | 3.3 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.7 | 1.7 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
1.6 | 4.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.5 | 6.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.5 | 7.5 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
1.5 | 6.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.3 | 3.9 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.3 | 10.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.3 | 3.8 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.2 | 3.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.2 | 4.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.2 | 6.0 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.2 | 9.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.1 | 9.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
1.1 | 3.4 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.1 | 3.3 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.1 | 3.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.1 | 2.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.1 | 3.2 | GO:1904395 | positive regulation of postsynaptic membrane organization(GO:1901628) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.1 | 3.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
1.1 | 3.2 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.1 | 3.2 | GO:0021553 | olfactory nerve development(GO:0021553) |
1.0 | 4.2 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
1.0 | 4.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.0 | 4.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.0 | 3.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.0 | 3.0 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
1.0 | 2.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
1.0 | 2.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.0 | 2.9 | GO:0007525 | somatic muscle development(GO:0007525) |
1.0 | 4.8 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.9 | 4.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.9 | 2.8 | GO:0060594 | mammary gland specification(GO:0060594) |
0.9 | 3.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.9 | 2.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.8 | 1.7 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.8 | 5.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 3.3 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.8 | 2.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.8 | 2.5 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.8 | 2.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.8 | 1.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.8 | 2.4 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.8 | 5.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.8 | 1.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.8 | 1.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.8 | 7.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.8 | 0.8 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.8 | 2.3 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.8 | 0.8 | GO:0048793 | pronephros development(GO:0048793) |
0.7 | 2.9 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.7 | 20.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.7 | 1.4 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.7 | 1.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.7 | 2.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.7 | 2.0 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.7 | 1.3 | GO:0021586 | pons maturation(GO:0021586) |
0.6 | 5.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.6 | 1.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.6 | 3.2 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.6 | 1.9 | GO:0031296 | B cell costimulation(GO:0031296) |
0.6 | 3.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.6 | 1.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 4.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.6 | 1.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.6 | 1.8 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.6 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 1.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.6 | 0.6 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.6 | 1.7 | GO:0006868 | glutamine transport(GO:0006868) |
0.6 | 1.7 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.6 | 2.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.6 | 1.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 0.6 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.5 | 1.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 1.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.5 | 2.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 1.6 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.5 | 1.6 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.5 | 1.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 1.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 1.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.5 | 2.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.5 | 4.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 2.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.5 | 1.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.5 | 1.0 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.5 | 1.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 7.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.5 | 5.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 1.9 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.5 | 1.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.5 | 1.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.5 | 1.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.5 | 7.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 10.6 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.5 | 1.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.5 | 1.0 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.5 | 22.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.5 | 1.4 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 3.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.5 | 5.1 | GO:0021544 | subpallium development(GO:0021544) |
0.5 | 1.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.5 | 1.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.4 | 1.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 0.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 1.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 1.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.4 | 1.3 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.4 | 1.8 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 1.7 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.4 | 0.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 1.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.4 | 3.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 1.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 4.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 0.4 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.4 | 1.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.4 | 1.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.4 | 6.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 1.6 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 1.6 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.4 | 2.3 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.4 | 0.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 3.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 3.9 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.4 | 1.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.4 | 1.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 3.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 2.6 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.4 | 1.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 1.5 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.4 | 0.4 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
0.4 | 1.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.4 | 1.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 0.7 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.4 | 1.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 2.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.4 | 0.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 0.4 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.4 | 1.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 1.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.4 | 3.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 2.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 1.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 2.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.3 | 1.7 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.3 | 1.4 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 3.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 1.7 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 8.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 1.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.3 | 5.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 1.0 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.3 | 2.6 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.3 | 1.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.3 | 0.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 1.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.3 | 1.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 0.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 3.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 0.3 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.3 | 0.9 | GO:0035482 | gastric motility(GO:0035482) |
0.3 | 0.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 1.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 3.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 1.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 1.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 0.8 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 0.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 3.6 | GO:0042407 | cristae formation(GO:0042407) |
0.3 | 0.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 0.8 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.3 | 0.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.3 | 0.8 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.3 | 1.9 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.3 | 1.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 1.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 0.3 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.3 | 1.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 0.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 1.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.5 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.3 | 0.8 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.3 | 0.8 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 1.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.3 | 0.5 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.3 | 1.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 1.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 0.2 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 1.7 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.5 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.5 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.7 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 0.2 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.2 | 0.4 | GO:0030421 | defecation(GO:0030421) |
0.2 | 15.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.7 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 1.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.4 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 0.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 0.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.2 | 0.4 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.4 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.2 | 0.6 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.2 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.2 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.2 | 0.2 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 0.8 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 0.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.2 | 1.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 1.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.4 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 4.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 1.6 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.4 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.2 | 2.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 2.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 1.0 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 1.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 0.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 1.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.9 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.4 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 0.7 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 1.7 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.7 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.2 | 0.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.2 | 0.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.2 | 0.4 | GO:0042048 | olfactory behavior(GO:0042048) |
0.2 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 1.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 2.2 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.2 | 3.9 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.2 | 0.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 0.5 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 1.8 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 3.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.2 | 1.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.2 | 0.3 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.2 | 1.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 0.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.7 | GO:1901018 | positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
0.2 | 0.5 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.3 | GO:0061548 | ganglion development(GO:0061548) |
0.2 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 1.3 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 2.5 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.2 | 0.8 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 0.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.2 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 0.9 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.6 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 0.6 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.5 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.2 | 0.3 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.2 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.5 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 0.5 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.4 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 0.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.3 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 3.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 1.0 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 0.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 1.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.6 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 2.0 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.3 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.4 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 1.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.6 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 1.4 | GO:0090382 | phagosome maturation(GO:0090382) |
0.1 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.4 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 1.2 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.1 | 0.2 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.4 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.4 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.1 | 0.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.6 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 1.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 1.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 10.8 | GO:0007612 | learning(GO:0007612) |
0.1 | 1.3 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.1 | 0.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.9 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 2.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.1 | 0.8 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.2 | GO:1902804 | negative regulation of synaptic vesicle transport(GO:1902804) |
0.1 | 0.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.5 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 2.2 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.1 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.3 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.1 | 0.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 7.7 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.1 | 0.2 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.9 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.8 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.5 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.1 | 0.4 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.7 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 1.0 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.9 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.2 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 1.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.2 | GO:0072679 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.5 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0002434 | immune complex clearance(GO:0002434) |
0.1 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.5 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 0.7 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 1.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.5 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.7 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.1 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.3 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.3 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.1 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.2 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 0.4 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.1 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.1 | 0.2 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.6 | GO:2001259 | positive regulation of cation channel activity(GO:2001259) |
0.1 | 0.5 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.8 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.5 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.6 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.2 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.1 | 0.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 1.0 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.1 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.1 | 0.2 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 1.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.1 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.3 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.6 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.4 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 0.5 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.1 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 0.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.1 | GO:0010963 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
0.1 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.5 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.1 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.2 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 1.4 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.7 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.4 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.3 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.1 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.4 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.1 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.1 | 0.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.7 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.5 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.4 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
0.1 | 0.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.0 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.1 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.0 | 0.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.0 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
0.0 | 0.0 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.0 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.0 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.0 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.3 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.0 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.0 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.0 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.0 | GO:1901563 | response to camptothecin(GO:1901563) |
0.0 | 0.0 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.1 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.0 | 0.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.1 | GO:0045738 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.1 | GO:0036314 | response to sterol(GO:0036314) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.3 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.3 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.3 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.0 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.1 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.0 | 0.1 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.0 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.0 | 0.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.1 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.0 | 0.4 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.0 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.1 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.1 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.0 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.1 | GO:0043987 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.1 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.0 | 0.0 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.3 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.0 | 0.1 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.0 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.0 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.0 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.0 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.0 | 0.0 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.0 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 0.0 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.0 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.0 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.0 | 0.0 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.0 | GO:0032747 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.0 | 0.0 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.0 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.0 | 0.0 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.0 | 0.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.0 | 0.0 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.2 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 20.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
3.0 | 23.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
2.9 | 8.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.8 | 8.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.5 | 12.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.1 | 1.1 | GO:0033010 | paranodal junction(GO:0033010) |
1.1 | 3.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
1.0 | 6.0 | GO:0071986 | Ragulator complex(GO:0071986) |
1.0 | 4.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.8 | 2.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.8 | 4.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.8 | 8.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 3.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.8 | 5.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.7 | 10.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.6 | 3.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.6 | 1.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.6 | 2.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.6 | 2.3 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.6 | 3.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.5 | 8.0 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 3.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 1.4 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.5 | 5.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.5 | 4.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.4 | 1.8 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 1.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 9.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 0.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 2.0 | GO:0097433 | dense body(GO:0097433) |
0.4 | 9.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 1.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 6.7 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 17.8 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 1.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 9.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 1.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 3.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.8 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 1.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 1.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 0.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 0.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 2.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 6.1 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 3.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 1.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 0.7 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 2.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.2 | 0.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 0.8 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 2.2 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.2 | 1.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 3.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 1.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 4.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 2.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 0.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 3.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.8 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 1.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 0.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.2 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.9 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 3.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.5 | GO:0030894 | replisome(GO:0030894) |
0.1 | 0.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 2.0 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 1.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 6.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.7 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 2.4 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 1.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 3.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 2.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.4 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.2 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.4 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.2 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 1.6 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.3 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 0.5 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 1.8 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 4.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.2 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 2.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.6 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 1.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 0.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 0.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.0 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 1.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.0 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 1.6 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.0 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 10.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.3 | 9.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.1 | 8.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.7 | 8.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.7 | 3.4 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.6 | 4.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.5 | 10.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.5 | 5.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.4 | 4.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.4 | 7.0 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.3 | 11.7 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
1.2 | 4.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.1 | 5.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 3.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
1.1 | 3.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.0 | 7.3 | GO:0030957 | Tat protein binding(GO:0030957) |
1.0 | 4.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 4.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.9 | 2.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 4.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.8 | 2.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.8 | 2.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.8 | 9.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.8 | 9.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.8 | 18.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.7 | 2.2 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.7 | 4.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.7 | 7.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.7 | 1.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.7 | 4.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 4.5 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 1.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.6 | 1.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.6 | 1.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.5 | 5.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.5 | 2.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 1.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 2.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 1.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.5 | 1.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 1.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 0.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.4 | 1.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 1.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 2.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 8.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 1.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.4 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 1.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 3.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 1.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.4 | 2.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.4 | 1.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 2.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.4 | 3.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.3 | 3.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 12.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 1.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 2.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 1.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 0.6 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 1.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 0.9 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.3 | 1.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 0.9 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.3 | 3.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 7.4 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.3 | 0.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.3 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 3.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 2.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 4.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 2.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 2.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 1.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.2 | 2.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 4.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.2 | 1.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 2.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 1.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 1.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 3.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 3.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 13.1 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 1.6 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 3.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 2.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 1.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.2 | GO:0030580 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.2 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 5.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 0.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.2 | 0.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 3.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 4.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 1.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 2.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 2.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 1.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 1.0 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 2.6 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 1.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 0.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 1.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.8 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 2.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.8 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 3.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 1.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 2.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.6 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 1.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 1.5 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 1.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 1.0 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 2.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.1 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 8.2 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 3.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.8 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 1.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 2.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 1.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 1.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 1.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 3.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.2 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.7 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 2.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.3 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.2 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.1 | 0.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 5.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.4 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 1.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 2.1 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.0 | 2.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 2.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 1.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 1.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.0 | 0.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.0 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 1.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.0 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.3 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.0 | 0.0 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.6 | 2.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 17.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 6.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 4.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 10.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.4 | 4.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.4 | 14.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 6.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 0.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 5.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 3.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 7.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 1.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 4.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 3.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 3.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 2.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 1.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 2.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 1.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 2.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.4 | PID P73PATHWAY | p73 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 11.4 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.9 | 9.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.7 | 5.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.5 | 2.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 5.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 5.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 11.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 4.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 8.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 0.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 5.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 7.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 2.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 2.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 4.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 4.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 7.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 3.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 5.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 3.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 0.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.2 | 5.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 3.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 2.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 2.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 1.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 2.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 1.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 4.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.1 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 2.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 3.0 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 1.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.3 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 3.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 4.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.1 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 0.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 1.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.7 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.2 | REACTOME SIGNALING BY GPCR | Genes involved in Signaling by GPCR |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.1 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |